Kuros Biosciences AG Cash Flow Quality Index
Kuros Biosciences AG cash flow quality index. Kuros Biosciences AG (KURN) has a Cash Flow Quality Index of -0.65x as of June 2026. Operating cash flow of CHF-2.24 Million is below net income of CHF3.47 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore KURN debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Kuros Biosciences AG (2015–2025)
Cash flow quality index of Kuros Biosciences AG from 2015 to 2025. Historical Cash Flow Quality Index for Kuros Biosciences AG across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. See net asset quality index of Kuros Biosciences AG to measure how much of total assets are equity-financed.
Kuros Biosciences AG Cash Flow Quality Index by Year (2015–2025)
Kuros Biosciences AG cash flow quality index by year from 2015 to 2025. Year-by-year earnings quality comparison for Kuros Biosciences AG. For the full cash flow conversion analysis, see how efficiently does Kuros Biosciences AG generate cash.
| Year | Quality Index | Operating CF (CHF) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | -0.07x | CHF-377.87K | CHF5.10 Million | ▲ +81.7% |
| 2015 | -0.40x | CHF-2.51 Million | CHF6.23 Million | — |